Global Oncology Intelligence
Get answers for your key business and research needs
Brand Team
Clinical Operations and Study Teams
Pipeline and BD Team
HEOR Team
Market Access Team
Business Intelligence Team
Quantify the cost of drug therapies by better understanding of the real-world standard of care. Size the market. Benchmark against competitor performance.
Examine drug utilization and treatment patterns to evaluate the real-world standard of care. Adoption.
Evaluate current standard of care. How does patient journey and standard of care differ across countries?
Benchmark adherence to clinical guidelines. Does my study protocol reflect real world populations and clinical practice? Compare biomarker testing rates.
Understand patient profiles and sub-populations. Which patient pops are underserved? Treatment pathways.
Inform on study protocols and feasibility.
How do healthcare stakeholders utilize Global Oncology Intelligence data
How is my brand being used in the real-world setting?
Does my clinical study protocol reflect real-world populations and clinical practice?
Which patient populations are underserved with effective therapies?
How is the competitive landscape evolving?
How does the patient journey and standard of care differ across countries?
How is the testing rate for key biomarkers evolving over time?
How is my brand being used in the real-world setting?
How does the patient journey and standard of care differ across countries?
How is the testing rate for key biomarkers evolving over time?
Which patient populations are underserved with effective therapies?
Does my clinical study protocol reflect real-world populations and clinical practice?
How is the competitive landscape evolving?